Gelatin/montmorillonite Cloisite 30 B (MMT) hybrid nanocomposites were prepared by blending gelatin with cloisite 30B in aqueous solution. The nano composites were characterized by using FTIR, SEM and XRD analysis. From the FTIR spectra the various groups present in the gelatin blend were monitored. The homogeneity, morphology and crystallinity of the blends were ascertained from SEM and XRD data, respectively . The results indicated that an intercalated or partially exfoliated nanocomposite could be achieved, and the properties of the composite were significantly improved.The drug release kinetics were investigated using Ofloxacin as the drug. The kinetics of the drug delivery system has been systematically studied. Drug release kinetics was analyzed by plotting the cumulative release data vs. time by fitting to an exponential equation which indicated the non-Fickian type of kinetics. The drug release was investigated at different pH medium and it was found that the drug release depends upon the pH medium as well as the nature of matrix.
INTRODUCTION
New environmental regulations, societal concerns and growing environmental awareness throughout the world have triggered the search for new products and processes that are compatible with the environment. Sustainability, industrial ecology, ecoefficiency, and green chemistry are the new principles and slogans that are guiding factors for the development of the next generations of product and process. Recently various biodegradable plant based and animal based products have been explored [1] [2] [3] .Gelatin is one kind of novel and promising biomaterial with many merits, including low cost, biodegradability, nontoxicity, and biocompatibility. Although gelatin can be used as a valuable biopolymer in tissue engineering 1 (e.g., wounddressing and bone scaffolding), its poor mechanical properties (especially in the wet state) limit its application as a structural biomaterial. Therefore, how to modify gelatin materials becomes a challenge for worldwide researchers. Many attempts such as vapor crosslink 4 orientation technique [5] [6] [7] and gelatinbased composites filled with hydroxyapatite 8 tricalcium phosphate9 and carbon fiber10 have been made and great progress has been achieved. However, the strength is still not high enough, especially in the wet state. Thermal properties of gelatin have been also improved mainly through an orientation technique11 However, there is still a long way to go before the application of high-performance gelatin or gelatin-based composites is perfected. Fortunately, the development of polymer-layered silicate nanocomposites provided us with some new opportunities.
Recently polymer/montmorillonite (MMT) nanocomposites have been extensively studied [12] [13] [14] With only a low content of MMT, the strength, Young's modulus, heat resistance, and solvent resistance of the composites can be greatly improved. [15] [16] [17] This may be promising method to enhance the gelatin properties for biomedical applications.
In the present research program, we wish to report a novel biomaterial-gelatin/ MMT (Cloisite 30 B) hybrid nanocomposite for the control release of Ofloxacin. The nano composites have been characterized by FTIR, SEM, XRD methods. The drug delivery has been carried out at different pH conditions and the results are encouraging. Figure 1 . UV spectrum of Ofloxacin ( Fig. 1) shows the UV spectra of Ofloxacin in aqueous acid (225, 226, 256 and 326 nm) and aqueous base (288 and 332 nm). Ofloxacin in aqueous solution has two peaks, a strong peak at 287 nm and a weak peak at 332 nm. The observed strong peak corresponds to the chromophore involving N _ 1 position to the carboxylic chromophore involving the nitrogen of the piperazinyl group to the carbonyl group while the weak absorption peak corresponds to the chromophore involving the nitrogen of the piperazinyl group to the carbonyl group. A survey of the literature reveals that gelatin is biodegradable, and biocompatible, has not been used for controlled delivery systems. In this communication we plan to report the preparation of gelatin blend by varying the proportion of cloisite30 B. The blends have been characterized using FTIR, SEM and XRD. The swelling kinetics as well as the drug delivery systems using Ofloxacin has also been studied at different pH and drug loading.
UV spectrum

EXPERIMENTAL
Materials: Gelatin (Type B, extracted from bovine skin) was purchased from Sigma Chemical. (St. Louis, MO).The Cloisite 30B was procured from Southern Clay Products, USA.
Ofloxacin was received as a gift sample from RANBAXY India. All other samples were of Analytical Grade.
Preparation of Nanocomposites:
One gram of gelatin powder was soaked in 50 ml deionized water and heated at 70°C to obtain a homogeneous solution .Calculated amount of Cloisite 30B( MMT) (1%, 2.5%, and 5%) was added to this slurry. The mixture was stirred for 8 hours at room temperature till a homogenate composite is formed. The product was poured into the specially self-made mold and dried at ambient temperature for several days.
Drug Loading
Required amount of gelatin (1gm in 50 ml) and nanoclay1% was taken in the mixture.
The mixture was continuously stirred with a mechanical stirrer. Ofloxacin of different loadings, i.e., 10 wt%, 20 wt%, 30 wt%, 40 wt% and 50 wt% were then added to the above mixture and stirred for 1 hr and then the composites were kept at room temperature for drying.
Dissolution experiments:
Dissolution experiments were performed at 37 0 C using the dissolution tester (Disso test, Lab India, Mumbai, India) equipped with six paddles at a paddle speed of 100 rpm. About 900 ml of phosphate buffer solution (pH 3.4 and 7.4) was used as the dissolution media to stimulate gastrointestinal tract (GIT) conditions. A 5-ml aliquot was used each time for analyzing the Ofloxacin content at a fixed time interval. The dissolution media was replenished with a fresh stock solution. The amount of Ofloxacin released was analyzed using a UV spectrophotometer (Systronics, India) at the λmax value of 287 nm.
Characterization Fourier Transmission Infra Red Spectroscopy (FTIR)
The FTIR spectrum of the gelatin blends were monitored using a BIORAD-FTS-7PC type FTIR spectrophotometer.
X-Ray Diffraction (XRD)
The change in gallery height of the blend was investigated by WAXD experiments, which were carried out using a X-ray diffractometer (BEDE D-3 system) with Cu Kα radiation at a generator voltage of 40 kV and a generator current of 100 mA. Samples were scanned from 2θ = 1-10 0 at a scanning rate of 2 0 /min.
Scanning Electron Microscopy (SEM):
The blending of the Gelatin Nanocomposites containing different concentrations was characterized using SEM (440, Leica Cambridge Ltd., Cambridge, UK). The film specimens were placed on the Cambridge standard aluminium specimen mounts (pin type) with double-sided adhesive electrically conductive carbon tape (SPI Supplies, West Chester, PA). The specimen mounts were then coated with 60% Gold The morphology of fracture surfaces of gelatin and composite are shown in ( Figure 4 ). The fracture surface of gelatin exhibits a smooth laminated structure . Comparatively, the fracture surface of composite seems coarse, indicating an improved toughness In-vitro drug release: The drug delivery system was developed for the purpose of bringing, up taking, retaining, releasing, activating, localizing and targeting the drugs at the right time period, dose and place
The biodegradable polymer can contribute largely to this technology by adding its own characters to the drugs. In this connection, some biodegradable polymer gelatin is commonly used as these polymers can be prepared in the moderate conditions, has a similar stiffness of the body and has an appropriate biodegradability and low crystallinity enough to be mixed well with many kinds of drug There are some formulations for the drug delivery systems, for example, films, gels, porous matrices, microcapsules, micro spheres, nanoparticles, polymeric micelles and polymer linked drugs Effect of pH: In order to investigate the effect of pH on the swelling of composite gelatin we have measured the % cumulative release in both pH 3.4 and 7.4 media. Cumulative release data indicates that by increasing the pH from 3.4 to 7.4, a considerable increase in the cumulative release is observed for all composites. From Fig. 5(A) and (B) , it is seen that the 50% drugpolymer composites have shown longer drug release rates than the other composites. Thus, drug release depends upon the nature of the polymer matrix as well as pH of the media. This suggests that the drugs in the blend can be used to be suitable for the basic environment of the large intestine, colon and rectal mucosa for which there are different emptying times.
Figure 6(A) & (B)
Interestingly, Ofloxacin is being released more rapidly at pH 7.4 than at pH 3.4, the release half times t50 (time required for releasing 50 wt% of drug) for 10%, 20%, 30%, 40%, 50% drug loading are 2.8, 1.8 and 1.7 h at pH 7.4, and 6.0, 5.0 and 4.4 h at pH 3.4, respectively are shown in Fig. 6(A) and (B) . More than 80 wt% Ofloxacin is released from composites at pH 7.4 within 8 h, whereas less than 44 wt% of the drug is released at pH 1.2 within 4 h. This suggests that the drugs in the composites can be used to be suitable for the basic environment. Further the electrostatic interaction of composites is more easily broken at pH 7.4 than at pH 3.4, leading to Ofloxacin being released more rapidly at pH 7.4 than 3.4. Effect of drug loading Fig. 6 displays the release profiles of drug from composites at different amounts of drug loadings. Release data show that formulations containing highest amount of drug (50%) displayed fast and higher release rates than those formulations containing a small amount of drug loading. The release rate becomes quite slower at the lower amount of drug in the matrix, due to the availability of more free void spaces through which a lesser number of drug molecules could transport.
Drug release kinetics
Drug release mechanism from matrices
From time to time, various authors have proposed several types of drug release mechanisms from matrices. It has been proposed that drug release from matrices usually implies water penetration in the matrix, hydration, swelling, diffusion of the dissolved drug (polymer hydro fusion), and/or the erosion of the gelatinous layer. Several kinetics models relating to the drug release from matrices, selected from the most important mathematical models, are described over here. However, it is worth mention that the release mechanism of a drug would depend on the dosage from selected, pH, nature of the drug and, of course, the polymer used. is the fractional drug release into dissolution medium and k 5 is a constant incorporating the structural and geometric characteristics of the tablet. The term 'n' is the diffusional constant that characterizes the drug release transport mechanism. When n = 0.5, the drug diffuses through and is release from the polymeric matrix with a quasiFickian diffusion mechanism. For n > 0.5, an anomalous, non-Fickian drug diffusion occurs. When n = 1, a non-Fickian, case II or zero-order release kinetics could be observed. Drug release kinetics was analyzed by plotting the cumulative release data vs. time by fitting to an exponential equation of the type as represented below. M t /M ∞ = Kt n Here, M t /M ∞ represents the fractional drug release at time t, k is a constant characteristic of the drug-polymer system and n is an empirical parameter characterizing the release mechanism. Using the least squares procedure, we have estimated the values of n and k for all the nine formulations and these data are given in Table 1 . The values of k and n have shown a dependence on the, % drug loading and polymer content of the matrix. Values of n for composites prepared by varying the amounts of drug containing 10, 20 and 30 wt% and keeping gelatin constant, ranged from 0.57 to 0.88 suggesting shift of drug transport from Fickian to anomalous type. However, the drug-loaded composites exhibited n values ranging from 0.96 to 1.57 (Table 1) , indicating a shift from erosion type release to a swelling controlled, non-Fickian type mechanism. The values of n more than 1 has also been recently reported This may be due to a reduction in the regions of low micro viscosity inside the matrix and closure of micro cavities during the swollen state of the polymer. Similar findings have been found elsewhere, wherein the effect of different polymer ratios on dissolution kinetics was investigated
CONCLUSION
Gelatin is a natural biodegradable polymer The blending of the composites has been carried out varying the proportion of nanoparticles ( cloisite 30 B)so that the composite can be a better drug carrier. From the FTIR spectra the different pendant group present in the composites have been ascertained. The morphology as well as the compatibility of the blends have been studied using SEM and XRD methods. From these studies the homogeneity of the blends has been predicted. The drug release depends upon the nature of the polymer matrix as well as pH of the media. The kinetics of the drug release has been investigated. The values of k and n have been computed. Based on the values of n nonFickian kinetics has been predicted.
